Novo Nordisk stock heads into earnings week as Wegovy pill scripts top 26,000
Novo Nordisk A/S Class B shares ended Friday at 369.6 Danish crowns, slipping 0.8 crown. Investors brace for a results-packed week, keen on fresh demand figures for the company’s new weight-loss drug.
Company hubNASDAQ:NOVOB.CO
Novo Nordisk (NOVOB.CO) Stock News & Analysis
Follow the latest Novo Nordisk (NOVOB.CO) company news, earnings coverage and investor analysis from TS2 Tech.
Save this hub to your TS2 Signalbook account.
- Latest update
- Articles in this hub
- 1
- Last 30 days
- 0
What investors are watching
- Earnings, guidance and financial performance
- Valuation, trading activity and market sentiment
- Strategy, catalysts and company-specific risks
TechStock² Updates
